DOD Pancreatic Cancer, Focused Pilot Award
ID: 353861Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Apr 29, 2024 12:00 AM
  4. 4
    Due Oct 3, 2024 12:00 AM
Description

The Department of the Army -- USAMRAA has posted a grant opportunity titled "DOD Pancreatic Cancer, Focused Pilot Award". This grant aims to support impactful and innovative concepts in pancreatic cancer research that can lead to significant advancements in patients' overall quality of life. The grant is focused on two patient-centered areas of research: access to healthcare and mental health/cancer-related outcomes and quality of life. The grant encourages studies on behaviors affecting access to healthcare, correlations between mental health and cancer outcomes, strategies to overcome psycho-social issues, behavioral studies on quality of life and decision-making, and development of nutritional or educational interventions for symptom management. The grant does not require preliminary data but expects a well-formulated, testable hypothesis based on strong scientific rationale. Clinical research studies are allowed, but interventional clinical trials, basic research, and preclinical animal studies are not supported. The proposed research should have a significant impact on improving outcomes and quality of life for individuals with pancreatic cancer. Innovation in study concept, research methods or technology, and adaptations of existing methods or technologies is highly encouraged. The grant has an estimated total program funding of $1,280,000 and expects to make 4 awards. The closing date for applications is October 3, 2024. For more information, you can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

Point(s) of Contact
Files
Title
Posted
4/30/2024
Similar Opportunities
DOD Pancreatic Cancer, Idea Development Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army -- USAMRAA is offering a grant opportunity titled "DOD Pancreatic Cancer, Idea Development Award". This grant aims to support the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements in improving outcomes for individuals with pancreatic cancer. The grant seeks to fund projects that make important and original contributions to advancing the understanding of pancreatic cancer and ultimately lead to improved outcomes for patients. The research should be innovative and may challenge existing paradigms or utilize new perspectives, methods, or technologies. The grant encourages the inclusion of personnel with experience in pancreatic cancer research and the use of preliminary data to support the proposed research. Additionally, the grant offers a higher level of funding for applications that propose to partner an experienced PI with an Early-Career Investigator wishing to pursue a career in pancreatic cancer research. The deadline for application submission is October 3, 2024. For more information, contact the CDMRP Help Desk at help@eBRAP.org or 301-682-5507.
DOD Pancreatic Cancer, Translational Research Partnership Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has posted a federal grant opportunity titled "DOD Pancreatic Cancer, Translational Research Partnership Award". This grant aims to support partnerships between clinicians and research scientists to accelerate the translation of promising ideas in pancreatic cancer towards clinical applications. The Translational Research Partnership Award seeks to foster collaborations between two independent investigators to address a central problem or question in pancreatic cancer that would be difficult to achieve through separate efforts. One partner in the collaboration must be a research scientist, while the other partner must be a clinician investigator. The award encourages the inclusion of experts from outside the pancreatic cancer field. The proposed projects should demonstrate the potential to have a significant impact on pancreatic cancer research and/or patient care. They should also leverage clinical information to address knowledge gaps, validate research findings, expand upon transformative results, and investigate novel findings. The application should provide evidence of the reciprocal transfer of information between basic and clinical science. The Translational Research Partnership Award requires the availability of necessary specimens, data, and/or interventions. Preliminary data relevant to pancreatic cancer and the proposed research project are required, although they do not necessarily need to be derived from studies of pancreatic cancer. The success of the project relies on the unique skills and contributions of each partner, and the proposed study must include plans for communication, coordination of research progress and results, and data transfer. This grant opportunity has an estimated total program funding of $4,800,000 and expects to make four awards. The closing date for applications is October 3, 2024. For more information and application submission requirements, interested applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507. By providing a comprehensive summary of this federal grant notice, we hope to support potential applicants in understanding the purpose and requirements of the DOD Pancreatic Cancer, Translational Research Partnership Award.
DoD Ovarian Cancer Research Program Pilot Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army -- USAMRAA has posted a grant opportunity titled "DoD Ovarian Cancer Research Program Pilot Award". This grant aims to support innovative concepts or theories in ovarian cancer research that could lead to critical discoveries or advancements in the field. The proposed research should focus on ovarian cancer using tissues, cell lines, datasets, or appropriate animal models. The grant seeks to expand or modify current thinking and approaches in ovarian cancer. The funding amount for this program is $4,800,000, and it is expected to award 10 grants. The deadline for application submission is August 6, 2024. For more information, you can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
DoD Rare Cancers, Concept Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army -- USAMRAA is offering a grant opportunity titled "DoD Rare Cancers, Concept Award". This grant supports highly innovative and potentially groundbreaking novel concepts in rare cancers. The Concept Award is intended to pursue serendipitous observations and does not require preliminary data. It aims to enhance the existing knowledge of rare cancers or develop innovative and novel investigations. The grant provides funding of $2,880,000 and expects to make 18 awards. The deadline for application submission is August 26, 2024. Researchers are encouraged to review the recommendations of the congressionally mandated Metastatic Cancer Task Force and submit research ideas that align with the FY24 RCRP priorities. The grant encourages research on health areas and conditions that affect women uniquely, as well as research involving nuclear medicine and related techniques. The grant also emphasizes adherence to rigorous study design and reporting standards. Applications from investigators within the military services and multidisciplinary collaborations are highly encouraged. Clinical trials are not allowed under this grant opportunity. For more information and to apply, contact the CDMRP Help Desk at help@eBRAP.org or 301-682-5507.
DoD Peer Reviewed Cancer, Impact Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army -- USAMRAA has posted a grant opportunity titled "DoD Peer Reviewed Cancer, Impact Award". This grant is in the category of Science and Technology and other Research and Development. The grant aims to support high-impact research that can accelerate promising findings toward clinical applicability in the field of cancer. The funding amount for this opportunity is $16,000,000, and it is expected to result in 10 awards. The grant does not require cost sharing or matching. The closing date for applications is September 26, 2024. The grant is open to all eligible applicants. The Impact Award is specifically focused on critical scientific or clinical cancer issues, with the potential to make a major near-term impact on at least one of the FY24 PRCRP Topic Areas and in at least one of the FY24 PRCRP Overarching Challenges. The proposed research should demonstrate the potential to improve patient outcomes in the field of cancer. It is not intended for basic research, but rather for translational or clinical research, including clinical trials. The grant requires applicants to provide preliminary data to support the feasibility of the study. It is intended to support established projects that have moved beyond basic research and have the potential to result in a near-term impact in clinical research or the clinic. The proposed research should be rigorously designed to include a statistical plan and data analysis plan. If applicable, the clinical trial must be initiated within the first year. For more information, interested applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.